header bar
  LeukemiaLinks - Your Link to the Latest Leukemia News  


FEBRUARY 2009 800.955.4572 Email the IRC Forward to a Friend
 

Welcome to LeukemiaLinks, your monthly source of leukemia news, research updates, clinical trials and events sponsored by The Leukemia & Lymphoma Society (LLS). For even more information, regularly visit our Patient Services and Disease Information Web sections.

news image

Latest Leukemia News

Adults with ALL Benefit from Pediatric-Type Intensive Chemotherapy
Pediatric-inspired chemotherapy markedly improves the outcome of adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL), at least up to the age of 45.   ::READ MORE NEWS::

LLS Features    ::READ MORE::
.....................................................................................................................................

Research Roundup
   ::READ MORE::
.....................................................................................................................................
IRC Question of the Month   
:: READ MORE::


Inspirational Stories

Inspirational ImageLearn how individuals touched by blood cancer cope. The LLS LifeMosaic Web feature offers hundreds of inspiring stories by patients and families. Read them or submit your own. This month, read about Julie's battle with AML.

Here to Help

For even more information, regularly visit the LLS Web site,
www.LLS.org, where many of our education programs are archived free of charge for convenient access 24/7.

If you haven't found what you're looking for in LeukemiaLinks , please call our Information Resource Center (IRC) to speak with trained information specialists. IRC staff are available Monday through Friday, 9 a.m. to 6 p.m. ET, toll free at (800) 955-4572; email
infocenter@lls.org; or click the "Live Patient Help" button on the www.LLS.org homepage.

 

 

Researcher Image

Commentary
Learn about new techniques for stem cell transplants. 

 


Clinical Trials

We invite you to use our LLS-supported TrialCheck® Web site , a clinical trial search service that offers patients and caregivers immediate access to listings of all leukemia clinical trials. Answer just a few simple questions and a list of available clinical trials related to your cancer will appear in an easy to read list of search results. 

You may also want to visit the National Cancer Institute's Cancer Trials Support Unit, providing resources and information on Phase III cancer treatment trials supported by the National Cancer Institute. :: SELECTED TRIALS::



Newsfeeds & Podcasts

Now you can get RSS Feeds and Podcasts from LLS.
:: CLICK HERE TO SIGN UP::

RSS - XML - Podcast - iTunes

Free eNewsletters
Free LLS eNewsletters deliver the latest information on research and treatment options, patient services programs and fundraising events.
::CLICK HERE TO SIGN UP ::


bottom bar

Latest Leukemia News

news image

Cancer Survivors Often Forgo Needed Care Due to Cost Concerns
Even with health insurance, more than 1 million cancer survivors living in the United States report forgoing needed medical care because of concerns about cost.

Research to Provide Information of Long-Term Effects of Childhood Cancer Treatment to Parents
Scientists have published findings on parents' needs for information about the neurocognitive late effects of treatment for childhood cancer.

Booklet Helps Cancer Patients Navigate Costly Care
The American Society of Clinical Oncology has released a guide to help cancer patients and their doctors communicate more effectively about the costs associated with treatment and care. 

Medicare Covers More Off-Label Uses of Cancer Drugs
Medicare has expanded its coverage of drugs for cancer treatments not approved by the U.S. Food and Drug Administration. Cancer doctors had clamored for the changes, saying that some of these treatments, known as off-label uses, were essential if patients were to receive the most up-to-date care. Others disagree. Learn more.

> Back to the top

LLS Features

calendar image

Archived Educational Events
Experience archived teleconferences and Webcasts free of charge, anytime.

My Personal CML Journey
LLS is proud to offer My Personal CML Journey, an interactive, online video education program. The feature follows the stories and experiences of two chronic myelogenous leukemia (CML) survivors. Learn more.

My Personal Clinical Trials Journey
Participate in this personalized and interactive program that follows the stories and experiences of three cancer survivors who have participated in clinical trials.

Co-Pay Assistance Program Broadens Funding
Qualified patients with chronic myelogenous leukemia can now receive up to $5,000 in assistance from LLS' Co-Pay Assistance Program. The aid helps offset prescription drug co-pays and other insurance-related expenses according to disease diagnosis.

LLS Advocacy
LLS's advocacy team represents the needs of cancer patients and their families in Washington, DC and state capitals throughout the United States. We need your help. Join our Advocates Network and make your voice heard. 

LLS Blog 
Celebrate our blog's birthday.

Two New Promotions Support LLS's Mission

  • Gap Inc's nationwide Give & Get Program (March 12-15, 2009) will benefit you with a special 30-percent discount coupon good at all Gap, Old Navy and Banana Republic stores. Five percent of all net sales go to LLS. Click here for details.
  • You can now have an LLS- or TNT-branded VISA credit card, personalized with any image you choose. LLS will receive $50 for each card used plus a percentage of all purchases. There's still time to receive your card and use it with the Gap Give & Get Program. Click here for details.

Upcoming Telephone Education Program

What: Myelodysplastic Syndromes (MDS): Exploring Current and Emerging Therapies
When: Thursday, March 26, 12 p.m. - 1:30 p.m. ET
Guest Speaker: Alan List, M.D., executive vice president, physician-in-chief, H. Lee Moffitt Cancer Center & Research Institute.

For more information, please call the IRC at (800) 955-4572 or regularly check the calendar section at www.LLS.org.


The Leukemia & Lymphoma Society is committed to curing blood cancers and helping patients and their families.
Learn the many ways you can help advance LLS's mission. 
 


> Back to the top

Research Roundup

links_image_micro2

Bendamustine is effective in p53-deficient B-cell neoplasms and requires oxidative stress and caspase-independent signaling  ::READ MORE:: 

Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD  ::READ MORE:: 


Hairy cell leukemia: current concepts  ::READ MORE:: 

Long-term disease-free survival after gemtuzumab, intermediate-dose cytarabine and mitoxantrone in patients with CD33+ primary resistant or relapsed acute myeloid leukemia  ::READ MORE::

Rituximab in combination with high-dose methylprednisolone for the treatment of fludarabine refractory high-risk chronic lymphocytic leukemia  ::READ MORE::

Therapy insight: management of cardiovascular disease in patients with cancer and cardiac complications of cancer therapy  ::READ MORE::

Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase leukemia  ::READ MORE::


>
Back to the top

Clinical Trials
Clinical Trials Image

Selected Trials

A Phase Ib Study of ISF35 in Combination with Chemotherapy (FCR) in Subjects with Relapsed, Refractory and/or 17p- CLL  ::READ MORE:: 

Phase III: Compare Bosutinib to Imatinib in Subjects with Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML  ::READ MORE:: 

Phase III: Lumiliximab with Fludarabine, Cyclophosphamide and Rituximab Versus FCR Alone in Subjects with Relapsed Chronic Lymphocytic Leukemia  ::READ MORE:: 

Phase II: Treosulfan, Fludarabine and Total-Body Irradiation in Treating Patients with Hematological Cancers Undergoing Donor Umbilical Cord Blood Transplant  ::READ MORE:: 

Phase III: Maternal Problem-Solving in Childhood Cancer  ::READ MORE:: 

> Back to the top

IRC Question of the Month
Q&A

Q: My health plan does not cover some of the drugs and tests my physician ordered to treat my leukemia. What can I do? 

A: If your health plan denies a claim for treatment that your physician thinks is medically necessary there are a number of things you can do.

  • Submit claims for all medical expenses even if you are not sure they are covered. Submit your bills as you receive them.

  • Contact your health plan and request a copy of your plan's coverage and appeal process in writing. When you make the call, get the name of the person you speak to and take the opportunity to establish an ongoing contact with a case manager with whom you can discuss any future issues that may arise. 

  • Start and maintain a file of all claims, claims-related documents and letters. In your file, keep a log of all calls related to your health claims reimbursement. Include the name of the person you spoke to and the dates of all telephone calls you make or receive. 

  • If you have submitted a claim that was denied, re-submit the claim with a copy of your denial letter. Ask your physician to write a statement explaining the treatment or services, the reason this treatment is medically necessary for you and how you will benefit. Your physician can also submit relevant peer-reviewed medical journal articles to document that the treatment is effective and necessary for your care.

These steps may resolve the claim. If not, you can submit the claim again and request a peer review. This provides the opportunity for your physician to discuss the treatment in detail with other physicians in the medical specialty. In the meantime, get help from your physician's office, your clinic or hospital to arrange to delay payment until your claim is resolved.

You can request help from the consumer services division of your state insurance department or commission and/or consider legal action if the claim is still not resolved.

Here are more resources to help you: 

  • LLS encourages you to contact our Information Resource Center at (800) 955-4572 or email us with any additional questions. 

  • LLS also provides supplementary financial assistance to patients in financial need. We offer $500 per year toward treatment-related expenses not covered by insurance (including tests, blood transfusions, chemotherapy, drugs, radiation therapy) and transportation to and from treatment. For more information about the Patient Financial Aid Program, click here.

  • Listen to the audio program Practical Tips for Managing Your Financial & Insurance Issues.

  • Order the free booklet Financial Health Matters and click here  for a printable guide of questions to ask about denial of coverage.

  • The Medicare Rights Center can help people to navigate the Medicare system. Counselors at (800) 333-4114 answer questions about insurance options, Medicare rights and protections, payment denials, appeals, complaints about care or treatment and Medicare bills.

  • The Patient Advocate Foundation (PAF) provides free services to help with Medicaid, disability, managed care, health insurance, medical debt and employment discrimination issues. PAF offers free legal assistance, in accordance with their guidelines, to help people obtain benefits from their insurance companies. You can contact PAF at (800) 532-5274.

  • Finally, the Cancer Legal Resource Center provides free information and resources about cancer-related legal issues. The Center has a free telephone assistance line at (866) 843-2572.

Please call our Information Resource Center (IRC) to speak with a trained information specialist. IRC staff are available Monday through Friday, 9 a.m. to 6 p.m. ET, toll free at (800) 955-4572. Contact us online or click the "Live Patient Help" button on the www.LLS.org homepage.


> Back to the top

Supported by an unrestricted
educational grant from
Cephalon Oncology
Donate Now
Contact Us: The Leukemia & Lymphoma Society, 1311 Mamaroneck Ave., White Plains, NY 10605, (800) 955-4572
Visit our e-Store & Special Offers page where you can support businesses that support LLS.